Still awaiting $ORIG ipo date- but that may be a good thing As the end of Q4 draws nearer by the hour, it appears we won’t be getting a clear IPO date from Origin therapeutics. However, as the psychedelic market continues to see all-time lows, I don’t think this is a bad thing.
Seeing as Origin has an incredibly strong portfolio of both publicly and privately held companies, the right IPO date that capitalizes on a swing in the market would give them an amazing opportunity to see some huge growth from IPO price.
The big thing holding this industry back is public acceptance and regulation. We all know that. I expect that 2022 will prove to be a big year of growth for the industry, in terms of continuing to lay the foundations to springboard off of. I think it’s smart of Origin’s management to hold off on IPO until such groundwork is laid, and the industry is ready to see a solid resurgence and broader investor interest.
We’ll hopefully see some updated guidance from Origin’s leadership early in Q1 as to what the company’s plans are for going public. As of now, we can expect the company to IPO under the ticker $ORIG in Canadian markets.
The company has a pretty enticing investor package that is available here. Definitely worth taking a look at IMO.
https://originpsychedelics.com/investors/?gclid=Cj0KCQiAq7COBhC2ARIsANsPATEmrShLff1iHcZFxWVMiPr7O3nO1k9HyWy8FMjBW-_7q9jxabfa35oaAjzIEALw_wcB